Clinical Trial Update: Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating sitagliptin (Januvia) for healing chronic diabetic foot ulcers in type 2 diabetes was terminated; results were posted in January 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: Georgetown University | Conditions: Type II Diabetes | Phase 4 | Status: TERMINATED | Results posted: 2017-01-06